‘Patchy’ UK AHSNs To Be Addressed Ahead Of 2023 Relicensing

A new remit for the NHS’ innovation vehicles, hopes for Integrated Care Systems and a new diagnostics trends report from Deloitte were on the agenda at a UK life sciences sector policy conference.

Shutterstock

The weeks of June-July had been earmarked by Rosalind Campion, director of the UK Office for Life Sciences (OLS), for compiling a one-year update to the government’s Life Sciences Vision. The Vision, issued in summer 2021, aims to create the optimum conditions for delivering innovation to patients.

But politics got in the way of those plans, Campion told a Westminster Health Forum policy conference on 18 July. (Also see "Podcast: MHRA Must Seize UK Digital And...

More from United Kingdom

More from Europe